A carregar...
Hemodynamic and clinical effects of selexipag in children with pulmonary hypertension
Selexipag is an oral prostacyclin receptor agonist; it was recently approved for use in adults with pulmonary arterial hypertension. The safety and efficacy of selexipag has not yet been determined in the pediatric population. We describe short-term hemodynamic and clinical data with selexipag thera...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
SAGE Publishing
2020-02-01
|
Colecção: | Pulmonary Circulation |
Acesso em linha: | https://doi.org/10.1177/2045894019876545 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|